A detailed history of Woodline Partners LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 678,154 shares of RNA stock, worth $21.5 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
678,154
Previous 645,658 5.03%
Holding current value
$21.5 Million
Previous $26.4 Million 18.09%
% of portfolio
0.28%
Previous 0.26%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$37.21 - $48.14 $1.21 Million - $1.56 Million
32,496 Added 5.03%
678,154 $31.1 Million
Q2 2024

Aug 14, 2024

BUY
$22.73 - $40.85 $1.35 Million - $2.42 Million
59,320 Added 10.12%
645,658 $26.4 Million
Q1 2024

May 15, 2024

BUY
$9.16 - $25.52 $4.84 Million - $13.5 Million
528,217 Added 908.82%
586,338 $15 Million
Q4 2022

Feb 14, 2023

BUY
$10.06 - $22.66 $201,531 - $453,947
20,033 Added 52.6%
58,121 $1.29 Million
Q3 2022

Nov 14, 2022

BUY
$15.46 - $23.43 $588,840 - $892,401
38,088 New
38,088 $622,000
Q1 2022

May 16, 2022

SELL
$14.2 - $23.78 $1.82 Million - $3.04 Million
-128,000 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$24.73 - $35.12 $1.11 Million - $1.58 Million
-44,978 Reduced 26.0%
128,000 $3.27 Million
Q3 2020

Nov 16, 2020

BUY
$23.35 - $35.94 $1.12 Million - $1.72 Million
47,978 Added 38.38%
172,978 $4.87 Million
Q2 2020

Aug 14, 2020

BUY
$26.62 - $31.5 $3.33 Million - $3.94 Million
125,000 New
125,000 $3.53 Million

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.65B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.